Non-diagnosis decisions and non-treatment decisions in elderly patients with cardiovascular diseases, do they

Related Experiment Videos

Henrike J Schouten1, Sabine van Ginkel, H L Koek

  • 1Department of Geriatrics, University Medical Center Utrecht, Utrecht, The Netherlands. h.j.schouten-3@umcutrecht.nl

Insights

Physicians face many medical choices. This review found non-diagnosis decisions (NDD) differ from non-treatment decisions (NTD) due to factors like physician characteristics, but more research is needed.

Area of Science:

  • Medical Decision-Making
  • Healthcare Management
  • Clinical Ethics

Background:

  • Increasing medical interventions require careful physician consideration.
  • Non-diagnosis decisions (NDD) are less understood than non-treatment decisions (NTD), despite uncertain consequences.

Purpose of the Study:

  • To investigate the determinants and reasons behind physicians' non-diagnosis decisions (NDD).
  • To compare NDD with non-treatment decisions (NTD) to determine if they are distinct entities.

Main Methods:

  • Systematic review of research on physicians' decisions to withhold or withdraw diagnostic or therapeutic interventions.
  • Screened 11,773 citations from Medline, Embase, and Cochrane databases.
  • Analyzed 45 relevant articles, including those on NDD in elderly cardiovascular patients.

Main Results:

  • Intervention proportionality was linked to NTD, not NDD.
  • Physician age and use of physician extenders were more associated with NDD.
  • Non-resuscitate directives correlated with NDD, but not NTD.

Conclusions:

  • NDD and NTD share some similarities but also exhibit key differences.
  • Current literature provides limited information on NDD.
  • Further research is necessary to establish NDD as a distinct clinical decision category.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...